| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| enVVeno Medical Corp | Director | Common Stock | 16,545 | $41,859 | $2.53 | 19 Dec 2024 | Direct |
| enVVeno Medical Corp | Director | Stock Options | 135,883 | 11 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NVNO | enVVeno Medical Corp | 11 Dec 2025 | 1 | $0 | 4 | Director | 15 Dec 2025, 20:40 |
| NVNO | enVVeno Medical Corp | 19 Dec 2024 | 1 | +$24,339 | 4 | Director | 23 Dec 2024, 06:03 |
| NVNO | enVVeno Medical Corp | 18 Dec 2024 | 1 | $0 | 4 | Director | 20 Dec 2024, 20:33 |
| NVNO | enVVeno Medical Corp | 05 Dec 2023 | 1 | $0 | 4 | Director | 07 Dec 2023, 17:06 |
| NVNO | enVVeno Medical Corp | 30 Nov 2022 | 1 | $0 | 4 | Director | 02 Dec 2022, 15:30 |
| NVNO | enVVeno Medical Corp | 13 Sep 2022 | 2 | $0 | 4 | Director | 16 Sep 2022, 16:05 |
| NVNO | enVVeno Medical Corp | 30 Nov 2021 | 1 | $0 | 4 | Director | 02 Dec 2021, 15:05 |
| NVNO | Hancock Jaffe Laboratories, Inc. | 13 Sep 2021 | 2 | $0 | 4 | Director | 15 Sep 2021, 21:50 |
| NVNO | Hancock Jaffe Laboratories, Inc. | 25 Aug 2021 | 1 | +$10,010 | 4 | Director | 27 Aug 2021, 15:19 |